• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用成像质谱流式细胞术对肺鳞状细胞癌肿瘤免疫微环境进行表征

Characterization of the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma Using Imaging Mass Cytometry.

作者信息

Li Ran, Lin Ying, Wang Yu, Wang Shaoyuan, Yang Yang, Mu Xinlin, Chen Yusheng, Gao Zhancheng

机构信息

Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, China.

The Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China.

出版信息

Front Oncol. 2021 Apr 1;11:620989. doi: 10.3389/fonc.2021.620989. eCollection 2021.

DOI:10.3389/fonc.2021.620989
PMID:33869005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8047498/
Abstract

BACKGROUND

Lung squamous cell carcinoma (LUSC) is a major subtype of non-small cell lung cancer. The tumor immune microenvironment (TIME) affects the anti-tumor immune response and the patient's prognosis, although the TIME in LUSC patients is incompletely understood.

METHODS

We retrospectively collected surgical specimens from patients with previously untreated primary LUSC. Histopathological examination was used to identify tumor regions and adjacent regions, and imaging mass cytometry was used to characterize the immune cells in those regions. The results were compared between regions and between patients.

RESULTS

We identified heterogeneity in the TIME on comparing different patients with LUSC, although the tumor region and adjacent region both exhibited an immune response to the tumor. The TIME typically included a large number of infiltrating and activated T-cells, especially CD8 T-cells, which closely interacted with the tumor cells in the tumor region. There was limited infiltration of B-cells, NK cells, and NKT cells, while the major immune suppressor cells were CD33 myeloid-derived cells. We also identified a novel population of CD3CD4 cells with high expression of Foxp3 and TNFα, which might modulate the tumor microenvironment and play a proinflammatory role in the TIME.

CONCLUSIONS

The TIME of LUSC appears to be immunogenic and heterogenous, with predominant infiltration of activated CD8 T-cells. The interactions between the tumor cells and T-cells facilitate the anti-tumor activity. A novel subpopulation of CD3CD4 cells with high TNFα and Foxp3 expression may modulate the tumor microenvironment and play a proinflammatory role.

摘要

背景

肺鳞状细胞癌(LUSC)是非小细胞肺癌的主要亚型。肿瘤免疫微环境(TIME)影响抗肿瘤免疫反应和患者预后,尽管LUSC患者的TIME尚未完全明确。

方法

我们回顾性收集了先前未经治疗的原发性LUSC患者的手术标本。采用组织病理学检查确定肿瘤区域和相邻区域,并用成像质谱流式细胞术对这些区域的免疫细胞进行表征。对不同区域之间以及患者之间的结果进行比较。

结果

比较不同LUSC患者时,我们发现TIME存在异质性,尽管肿瘤区域和相邻区域均对肿瘤表现出免疫反应。TIME通常包括大量浸润和活化的T细胞,尤其是CD8 T细胞,它们在肿瘤区域与肿瘤细胞密切相互作用。B细胞、NK细胞和NKT细胞的浸润有限,而主要的免疫抑制细胞是CD33髓系来源细胞。我们还鉴定出一群高表达Foxp3和TNFα的CD3CD4细胞,它们可能调节肿瘤微环境并在TIME中发挥促炎作用。

结论

LUSC的TIME似乎具有免疫原性且异质性,以活化的CD8 T细胞为主浸润。肿瘤细胞与T细胞之间的相互作用促进了抗肿瘤活性。一种高表达TNFα和Foxp3的新型CD3CD4细胞亚群可能调节肿瘤微环境并发挥促炎作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f5/8047498/34f8fac07bf0/fonc-11-620989-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f5/8047498/308c10739ba2/fonc-11-620989-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f5/8047498/08938904e771/fonc-11-620989-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f5/8047498/34f8fac07bf0/fonc-11-620989-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f5/8047498/308c10739ba2/fonc-11-620989-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f5/8047498/08938904e771/fonc-11-620989-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53f5/8047498/34f8fac07bf0/fonc-11-620989-g003.jpg

相似文献

1
Characterization of the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma Using Imaging Mass Cytometry.利用成像质谱流式细胞术对肺鳞状细胞癌肿瘤免疫微环境进行表征
Front Oncol. 2021 Apr 1;11:620989. doi: 10.3389/fonc.2021.620989. eCollection 2021.
2
Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.基于癌症干性的肺腺癌和肺鳞癌预后免疫相关基因特征。
Front Endocrinol (Lausanne). 2021 Oct 21;12:755805. doi: 10.3389/fendo.2021.755805. eCollection 2021.
3
Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients.四个枢纽基因调节肿瘤浸润免疫细胞、肿瘤微环境中的抗肿瘤免疫以及肺鳞癌患者的生存结局。
Aging (Albany NY). 2021 Jan 10;13(3):3819-3842. doi: 10.18632/aging.202351.
4
Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.肺鳞状细胞癌中肿瘤抑制基因的综合基因组和转录组分析及其对肿瘤微环境和免疫的作用
Front Immunol. 2021 Feb 25;12:598671. doi: 10.3389/fimmu.2021.598671. eCollection 2021.
5
A tumor cornification and immune-infiltration-based scheme for anti-PD-1 plus chemotherapy response in advanced squamous cell lung carcinoma.一种基于肿瘤角化和免疫浸润的晚期肺鳞状细胞癌抗PD-1联合化疗反应方案。
Med. 2025 Feb 14;6(2):100516. doi: 10.1016/j.medj.2024.09.005. Epub 2024 Oct 11.
6
Integrative analysis of genomic alteration, immune cells infiltration and prognosis of lung squamous cell carcinoma (LUSC) to identify smoking-related biomarkers.整合分析肺鳞癌(LUSC)的基因组改变、免疫细胞浸润和预后,以鉴定与吸烟相关的生物标志物。
Int Immunopharmacol. 2020 Dec;89(Pt A):107053. doi: 10.1016/j.intimp.2020.107053. Epub 2020 Oct 9.
7
CMTM6 is positively correlated with PD-L1 expression and immune cells infiltration in lung squamous carcinoma.CMTM6 与肺鳞癌中的 PD-L1 表达和免疫细胞浸润呈正相关。
Int Immunopharmacol. 2020 Nov;88:106864. doi: 10.1016/j.intimp.2020.106864. Epub 2020 Aug 28.
8
Immune Infiltration Landscape in Lung Squamous Cell Carcinoma Implications.肺鳞状细胞癌的免疫浸润景观及其意义。
Biomed Res Int. 2020 Oct 10;2020:5981870. doi: 10.1155/2020/5981870. eCollection 2020.
9
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.基质 PD-L1 阳性调节性 T 细胞和 PD-1 阳性 CD8 阳性 T 细胞定义了不同亚组非小细胞肺癌对 PD-1/PD-L1 阻断免疫治疗的反应。
J Thorac Oncol. 2018 Apr;13(4):521-532. doi: 10.1016/j.jtho.2017.11.132. Epub 2017 Dec 18.
10
m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma.m5C RNA甲基化调节剂预测肺鳞状细胞癌的预后并调节其免疫微环境
Front Oncol. 2021 Jun 9;11:657466. doi: 10.3389/fonc.2021.657466. eCollection 2021.

引用本文的文献

1
From surfing to diving into the tumor microenvironment through multiparametric imaging mass cytometry.从通过多参数成像质谱流式细胞术进行表面探索到深入肿瘤微环境。
Front Immunol. 2025 Apr 11;16:1544844. doi: 10.3389/fimmu.2025.1544844. eCollection 2025.
2
Simultaneous immunomodulation and epithelial-to-mesenchymal transition drives lung adenocarcinoma progression.同时发生的免疫调节和上皮-间质转化驱动肺腺癌进展。
bioRxiv. 2025 Feb 22:2025.02.19.637138. doi: 10.1101/2025.02.19.637138.
3
Fluorescence Lifetime Multiplexing (FLEX) for simultaneous high dimensional spatial biology in 3D.

本文引用的文献

1
Characterization of an Aggregated Three-Dimensional Cell Culture Model by Multimodal Mass Spectrometry Imaging.多模态质谱成像技术对聚集三维细胞培养模型的表征。
Anal Chem. 2020 Sep 15;92(18):12538-12547. doi: 10.1021/acs.analchem.0c02389. Epub 2020 Aug 14.
2
A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.基于肺鳞癌免疫相关基因的与患者预后和肿瘤免疫微环境相关的稳健标志物。
Int Immunopharmacol. 2020 Nov;88:106856. doi: 10.1016/j.intimp.2020.106856. Epub 2020 Aug 7.
3
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.
荧光寿命多重检测(FLEX)技术可用于在 3D 环境中进行同时的高维空间生物学研究。
Commun Biol. 2024 Aug 18;7(1):1012. doi: 10.1038/s42003-024-06702-8.
4
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer.髓系和 T 细胞的空间结构调控肺癌的免疫逃逸和临床结局。
Cancer Discov. 2024 Jun 3;14(6):1018-1047. doi: 10.1158/2159-8290.CD-23-1380.
5
Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer.多指标成像质谱细胞术分析胰腺癌的临床前模型。
Int J Mol Sci. 2024 Jan 23;25(3):1389. doi: 10.3390/ijms25031389.
6
Advancing Understanding of Non-Small Cell Lung Cancer with Multiplexed Antibody-Based Spatial Imaging Technologies.利用基于多重抗体的空间成像技术加深对非小细胞肺癌的理解
Cancers (Basel). 2023 Sep 29;15(19):4797. doi: 10.3390/cancers15194797.
7
Advances in mass cytometry and its applicability to digital pathology in clinical-translational cancer research.质谱流式细胞术的进展及其在临床转化癌症研究中对数字病理学的适用性。
Adv Lab Med. 2021 Nov 24;3(1):5-29. doi: 10.1515/almed-2021-0075. eCollection 2022 Mar.
8
Using Artificial Intelligence to Identify Tumor Microenvironment Heterogeneity in Non-Small Cell Lung Cancers.利用人工智能识别非小细胞肺癌肿瘤微环境异质性。
Lab Invest. 2023 Aug;103(8):100176. doi: 10.1016/j.labinv.2023.100176. Epub 2023 May 12.
9
RGN as a prognostic biomarker with immune infiltration and ceRNA in lung squamous cell carcinoma.RGN 作为肺鳞癌的预后生物标志物,与免疫浸润和 ceRNA 相关。
Sci Rep. 2023 May 9;13(1):7553. doi: 10.1038/s41598-023-32217-z.
10
Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy.单细胞技术揭示的非小细胞肺癌免疫生物学:免疫治疗患者生物标志物开发的意义。
Semin Immunopathol. 2023 Jan;45(1):29-41. doi: 10.1007/s00281-022-00973-1. Epub 2022 Nov 21.
肿瘤免疫微环境与免疫评分在癌症预后和治疗疗效中的作用
Nat Rev Cancer. 2020 Nov;20(11):662-680. doi: 10.1038/s41568-020-0285-7. Epub 2020 Aug 4.
4
Mechanism of acquired resistance to nivolumab in lung squamous cell carcinoma: case report and review of the literature.肺鳞癌获得性对纳武利尤单抗耐药的机制:病例报告及文献复习。
Immunotherapy. 2020 Sep;12(13):957-964. doi: 10.2217/imt-2020-0038. Epub 2020 Jul 19.
5
Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma.开发和验证肺鳞癌新型免疫相关预后模型。
Int J Med Sci. 2020 Jun 1;17(10):1393-1405. doi: 10.7150/ijms.47301. eCollection 2020.
6
Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma.存在 34 基因标志物是鳞状非小细胞肺癌的有利预后标志物。
J Transl Med. 2020 Jul 3;18(1):271. doi: 10.1186/s12967-020-02436-3.
7
Immune microenvironment composition in non-small cell lung cancer and its association with survival.非小细胞肺癌中的免疫微环境组成及其与生存的关联。
Clin Transl Immunology. 2020 Jun 12;9(6):e1142. doi: 10.1002/cti2.1142. eCollection 2020.
8
CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment.CLEC3B作为肺癌潜在的诊断和预后生物标志物及其与免疫微环境的关联
Cancer Cell Int. 2020 Apr 1;20:106. doi: 10.1186/s12935-020-01183-1. eCollection 2020.
9
Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma.免疫相关基因在肺腺癌和肺鳞癌肿瘤微环境中的预后价值。
Aging (Albany NY). 2020 Mar 25;12(6):4757-4777. doi: 10.18632/aging.102871.
10
Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma.癌症相关成纤维细胞通过诱导产生 ROS 的单核细胞 MDSC 促进肺鳞状细胞癌的免疫抑制。
Cancer Immunol Res. 2020 Apr;8(4):436-450. doi: 10.1158/2326-6066.CIR-19-0507. Epub 2020 Feb 19.